United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
499.73
-1.54 (-0.31%)
Aug 14, 2026, 4:00 PM EDT - Market closed

United Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,8031,5571,6971,208961.2894.8
Short-Term Investments
859.11,3631,5701,7861,8781,036
Cash & Short-Term Investments
2,6622,9203,2672,9942,8391,931
Cash Growth
-12.67%-10.61%9.12%5.47%47.03%5.21%
Accounts Receivable
310.3350.2279.3278.9220.4198.7
Other Receivables
---2170-
Receivables
310.3350.2279.3299.9290.4198.7
Inventory
193.8183.1157.9111.810293.8
Other Current Assets
317.3248.9169.7145.2149.2100.4
Total Current Assets
3,4843,7033,8743,5513,3802,324
Property, Plant & Equipment
1,9301,7301,2221,045861.5780.9
Long-Term Investments
1,2331,8311,5341,9381,3451,681
Goodwill
-32.332.333.72828
Other Intangible Assets
114.184.279.680.516.516.6
Long-Term Deferred Tax Assets
311.6357.7458.4394.8327.7261.9
Other Long-Term Assets
147.9143.1163.1123.385.877.1
Total Assets
7,2207,8807,3647,1676,0455,169

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
497.87.165.64.13.8
Accrued Expenses
-506.9369.3358.3326.1291.4
Current Portion of Long-Term Debt
--300400--
Current Portion of Leases
-7.3----
Other Current Liabilities
11039.362.840.51310.2
Total Current Liabilities
607.8560.6738.1804.4343.2305.4
Long-Term Debt
---300800800
Long-Term Leases
-30.3----
Pension & Post-Retirement Benefits
-28.821.318.33248.9
Other Long-Term Liabilities
212164.1160.659.572.655.9
Total Liabilities
819.8783.89201,1821,2481,210

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.80.80.80.70.70.7
Additional Paid-In Capital
2,8962,7982,6992,5492,3882,245
Retained Earnings
9,1658,5577,2226,0275,0424,315
Treasury Stock
-5,645-4,260-3,475-2,579-2,579-2,579
Comprehensive Income & Other
-16.20.9-3.4-12.8-55.5-23
Shareholders' Equity
6,4007,0966,4445,9854,7973,959
Total Liabilities & Equity
7,2207,8807,3647,1676,0455,169

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-37.6300700800800
Net Cash (Debt)
3,8034,6594,4424,2043,3552,781
Net Cash Growth
-23.42%4.89%5.67%25.31%20.65%27.28%
Net Cash Per Share
81.1097.2791.5984.5969.1758.79
Filing Date Shares Outstanding
42.8943.8344.9147.0646.345.13
Total Common Shares Outstanding
42.6843.6444.8347.0446.0345.11
Working Capital
2,8763,1423,1362,7473,0372,018
Book Value Per Share
149.97162.60143.74127.23104.2087.77
Tangible Book Value
6,2866,9806,3325,8714,7523,914
Tangible Book Value Per Share
147.30159.93141.24124.80103.2486.78
Land
275.8266.5181.9148142.7132.6
Buildings
955.1944.7863.8685.3636.7612.7
Machinery
517.3493.6449.7381.2353.9322.9
Construction In Progress
794592.7218.2259.1110.955.1
SEC Filings: 10-K · 10-Q